Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Fever; Muscle ache; Injection site pain; Tiredness; Drowsiness; Maternal exposure during breast feeding; breasfeeding; breastfeeding; This is a spontaneous report from a contactable consumer. This is the first of two reports. The first report is a report downloaded from the regulatory authority report number is GB-MHRA-WEBCOVID-202106051517171690-KORRP, Safety Report Unique Identifier GB-MHRA-ADR 25426018. This consumer reported information for both mother and fetus/baby. This is a maternal report. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jun2021 (at the age of 35 years) as the 1st dose, single for COVID-19 immunisation. Medical history included ongoing breast feeding, suspected COVID-19 from 30Mar2020 to 03Apr2020. Not had a COVID-19 test. Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. Patient has not tested positive for COVID-19 since having the vaccine. The patient experienced fever, muscle ache, injection site pain, tiredness, drowsiness, and maternal exposure during breast feeding on 04Jun2021. The events were considered medically significant. Patient was taking regular paracetamol. The patient has not recovered from the events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : GB-PFIZER INC-2021668836 Fetus/baby case
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166